Home All News Page 2

All News

Internet And Biotech Related News

Adding Immix Biopharma (IMMX) to 2022 Biotech 12 Pack List.

Added to 12 Biotech Stocks we Expect to Double List. The Original Biotech 6-Pack from 2020, is Growing to...

Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial TORONTO, April...

Revive (RVVTF) Hits a Snag?

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 First our summary."FDA provided communication that...
internet stock review

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial...

Biotech Stock Review Adds Hancock Jaffe (HJLI) $1.05 to Watch List.

Adding to Watch List on Heels of 90 Day Results, From First Small 'In-Man' Trial to Treat Chronic Venous Insufficiency affecting the...
biotech stock review

7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion...
Immunomedics IMMU, Biotech Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value.

Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If...
biotech stock review

Adding Fluidigm (FLDM) $6.14, to Corona Stock Watch List.

And we have our first 'bounce' candidate of the dip.. LIVE CHART
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.

Latest article

ARK VS. SARK | PAST STANCES

Long Ark Innovation 10/3/2022 | $37.90 #ARK, #ARKK, #SARK

ARK vs. SARK

Ever get really, really bearish and really, really wish you could find a simple way to make money in a bear market?

Adding ‘Internet of Things,’ Direct Communications (DCSX) $1.17 to the Watch List.

Chris Bursey, Member of Verizon's Internet of Things (IOT) Advisory Council, Charges Ahead as CEO of Direct Communication (DCSX).